Sales and Marketing

Showing 15 posts of 11524 posts found.

novo_flag

European approval for Novo’s Esperoct in haemophilia A

June 21, 2019 Medical Communications, Sales and Marketing Esperoct, Novo Nordisk, haemophilia, pharma

The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …
shutterstock_114045100

Sanofi to axe 466 R&D positions in Germany and France

June 21, 2019 Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …
shutterstock_235920349

GSK offers concessions ahead of planned venture with Pfizer

June 21, 2019 Medical Communications, Sales and Marketing GSK, Pfizer, pharma

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …

Alimera Sciences secures NICE recommendation for uveitis eye implant

June 21, 2019 Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis

Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …

Catalent to purchase Italy manufacturing facility from BMS

June 20, 2019 Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, Cataletnt, pharma

Bristol-Myers Squibb has reached an agreement with Catalent for the latter to acquire its Anagni, Italy-based facility which specialises in …
28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019 Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019 Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
lynparza

EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer

June 18, 2019 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019 Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

Boehringer Ingelheim open new plant in Catalonia

June 17, 2019 Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona. The new …
facilities_lg06

Dr Reddy’s sells of two migraine treatments to Upsher-Smith Laboratories in deal worth $110 million

June 17, 2019 Sales and Marketing

Indian firm Dr Reddy’s has agreed to sell two migraine treatments to American firm Upsher-Smith Laboratories in a deal worth …
image_credit_united_states_mission_geneva

WHO decide not to declare global emergency

June 17, 2019 Sales and Marketing Ebola, UN, WHO, global emergency, health, pharma

The WHO has decided not to declare the Ebola crisis in the Congo a global emergency. While the WHO said …
29496564944_a9faceb1c2_z

Drugmakers sue Trump over prices in TV ads

June 17, 2019 Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …
16578744517_ed4293d3e7_z

Patient dies after receiving faecal transplant

June 17, 2019 Sales and Marketing Adverse Event, E.Coli. AMR, FDA, faecal transplant, pharma

A person has died after experiencing an adverse event related to a faecal transplant. The FDA has warned that two …
The Gateway to Local Adoption Series

Latest content